← back to search

Tea Monk Fries

Novo Nordisk (Denmark) · DK
Area of research
Endocrinology, Diabetes and Metabolism · Molecular Biology
Research interest
Research interests include Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Heart Failure Treatment and Management, and Pancreatic function and diabetes.
h-index
7
citations
651
works
10
NIH funding
—
primary concept
Liraglutide
email
✉ Find email ↗

Recent publications

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
Diabetes Care 2020cited by 167position: middledoi
Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the <scp>LEADER</scp> and <scp>SUSTAIN</scp> 6 trials
Diabetes Obesity and Metabolism 2020cited by 93position: middledoi
Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials
Diabetes Obesity and Metabolism 2019cited by 30position: middledoi
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke
Circulation 2018cited by 117position: middledoi
Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease
Circulation 2018cited by 106position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Stephen C. Bain · Swansea Bay University Health Board5 papers (2018–2020)Bernard Zinman · Lunenfeld-Tanenbaum Research Institute5 papers (2018–2020)John B. Buse · University of North Carolina at Chapel Hill5 papers (2018–2020)Richard E. Pratley · AdventHealth Translational Research Institute5 papers (2018–2020)Subodh Verma · Institute for Work & Health4 papers (2018–2020)Søren Rasmussen · Novo Nordisk (Denmark)4 papers (2018–2020)Michael A. Nauck · Universitätsmedizin Greifswald4 papers (2018–2020)Neil R Poulter · Imperial College London3 papers (2018–2020)Lawrence A. Leiter · St. Michael's Hospital3 papers (2018–2020)Deepak L. Bhatt · Technische Universität Dresden3 papers (2018–2020)Steven P. Marso · Southwestern Medical Center2 papers (2018–2018)David D. Ørsted · Novo Nordisk (Denmark)2 papers (2018–2020)C. David Mazer · University of Toronto2 papers (2019–2020)Johannes F.E. Mann · Friedrich-Alexander-Universität Erlangen-Nürnberg2 papers (2018–2020)Darren K. McGuire · Saint Luke's Health System1 papers (2020–2020)— · 1 papers (2019–2019)Marie Mide Michelsen · Novo Nordisk (Denmark)1 papers (2018–2018)Martin Linder · Stockholm South General Hospital1 papers (2020–2020)Stuart Pocock · London School of Hygiene & Tropical Medicine1 papers (2020–2020)Steven E. Nissen · Esperion Therapeutics (United States)1 papers (2020–2020)